LPS-induced liver injury in D-galactosamine-sensitized mice requires secreted TNF-α and the TNF-p55 receptor

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 278, Issue 5 47-5, 2000, Pages

  Nowak, Monika ^a   Gaines, Gregory C ^a   Rosenberg, Jason ^a   Minter, Rebecca ^a   Bahjat, F R ^a   Rectenwald, John ^a   Mackay, Sally L D ^a   Edwards III, Carl K ^a   Moldawer, Lyle L ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Apoptosis; Hepatitis; Septic shock

Indexed keywords

GALACTOSAMINE; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; HEPATITIS; KNOCKOUT MOUSE; LIVER INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0034048115     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.2000.278.5.r1202     Document Type: Article

References (7)

1. Alexopoulou L, Pasparakis M, and Kollias G. A murine transmembrane tumor necrosis factor (TNF) transgene induces arthritis by cooperative p55/p75 TNF receptor signaling. Eur J Immunol 27: 2588-2592, 1997.
2. Bohlinger I, Leist M, Gantner F, Angermuller S, Tiegs G, and Wendel A. DNA fragmentation in mouse organs during endotoxic shock. Am J Pathol 149: 1381-1393, 1996.
3. Crowe PD, Walter BN, Mohler KM, Otten Evans C, Black RA, and Ware CF. A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes. J Exp Med 181: 1205-1210, 1995.
4. Espevik T and Nissen Meyer J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods 95: 99-105, 1986.
5. Gearing AJH, Beckett P, Christodoulou M, Churchill M, Clements JM, Crimmin M, Davidson AH, Drummond AH, Galloway WA, Gilbert R, Gordon JL, Leber TM, Mangan M, Miller K, Nayee P, Owen K, Patel S, Thomas W, Wells G, Wood LM, and Woolley K. Matrix metalloproteinases and processing of pro-TNF-α. J Leukoc Biol 57: 774-777, 1995.
6. Grell M, Douni E, Wajant H, Lohden M, Clauss M, Maxeiner B, Georgopolous S, Lesslauer W, Kollias G, Pfizenmaier K, and Scheurich P. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83: 793-802, 1995.
7. Grell M, Scheurich P, Meager A, and Pfizenmaier K. TR60 and TR80 tumor necrosis factor (TNF)-receptors can independently mediate cytolysis. Lymphokine Cytokine Res 12: 143-148, 1993.